Expression of HVEM and BTLA have previously been demonstrated to increase lymphocytes in both trauma- and sepsis-induced critical illness, with associated impact on overall septic mortality and changes in nosocomial infection risk (24, 26). The gene discussed is TNFRSF14; the disease is nosocomial infection.